Sign in

CIK 0001660334

  • Non-accelerated filer
  • Smaller reporting company

Verrica Pharmaceuticals Inc.

Sign in to watch
Ticker
VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463137900
Phone
+1 484-453-3300
Business address
44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
  1. 4 Open-market sale 10% owner sold 1,000 shares at an average $8.25 ($8,248)
  2. 4 Open-market sale 10% owner sold 4,100 shares at an average $8.02 ($32,871)
  3. 4 Open-market sale 10% owner sold 12,439 shares at an average $7.35 ($91,474)
  4. 4 Open-market sale 10% owner sold 4,215 shares at an average $9.57 ($40,331)
  5. 4 Open-market buy Director bought 70,200 shares at an average $14.15 ($993,021)
  6. 4 Open-market buy Chief Operating Officer bought 2,500 shares at $16.52 ($41,300)
  7. 4 Open-market buy President and CEO bought 300 shares at $16.36 ($4,908)
  8. 4 Open-market buy President and CEO bought 2,505 shares at an average $15.69 ($39,310)
  9. 4 Open-market buy President and CEO bought 4,500 shares at $15.00 ($67,500)
  10. 4 Open-market buy Chief Operating Officer bought 3,000 shares at $15.00 ($45,000)
  11. 4 Open-market buy Chief Financial Officer bought 3,000 shares at $15.00 ($45,000)
  12. 4 Open-market buy Chief Commercial Officer bought 1,000 shares at $15.00 ($15,000)
  13. 4 Open-market buy Director bought 300,000 shares at $15.00 ($4,500,000)
  14. 4 Open-market buy Director bought 33,000 shares at $15.08 ($497,640)
  15. 4 Open-market buy 10% owner bought 1,000,000 shares at $15.00 ($15,000,000)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Conversion Director acquired 394,295 shares (conversion)
  18. 4 Conversion Director acquired 200,734 shares (conversion)
  19. 4 Conversion Director acquired 9,144,317 shares (conversion)
  20. 4 Derivatives Options or other derivatives

Page 12 of 13 · 253 filings